Ever since the
discovery of human embryonic stem cells, one of the main goals was to use them
for treating diseases caused by dysfunctional or damaged cells. Diabetes is one
of such diseases. Beta cells in pancreas produce insulin and the destruction of
these cells causes Type I diabetes.
But efforts to turn
embryonic stem cells into beta cells proved to be “frustratingly slow.”
No comments:
Post a Comment